MIRA (Mira Pharmaceuticals) Total Liabilities: $0.12 Mil (As of Mar. 2026)


MIRA Mira Pharmaceuticals Inc MIRA
13 GF Score
Price $0.93
! 1 Warning Sign
View Full Analysis

What is Mira Pharmaceuticals Total Liabilities?

Mira Pharmaceuticals MIRA -0.26% 13 Total Liabilities is $0.12 Mil as of Mar. 2026. GuruFocus rates MIRA with a GF Score™ of 13/100. The stock has 1 warning sign investors should review.

Mira Pharmaceuticals's Total Liabilities for the quarter that ended in Mar. 2026 was $0.12 Mil.

Mira Pharmaceuticals's quarterly Total Liabilities increased from Sep. 2025 ($0.08 Mil) to Dec. 2025 ($0.70 Mil) but then declined from Dec. 2025 ($0.70 Mil) to Mar. 2026 ($0.12 Mil).

Mira Pharmaceuticals's annual Total Liabilities increased from Dec. 2023 ($0.56 Mil) to Dec. 2024 ($0.72 Mil) but then declined from Dec. 2024 ($0.72 Mil) to Dec. 2025 ($0.70 Mil).

Mira Pharmaceuticals Total Liabilities Historical Data

* Premium members only.

The historical data trend for Mira Pharmaceuticals's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Mira Pharmaceuticals Total Liabilities Chart

Mira Pharmaceuticals Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Total Liabilities
1.09 1.45 0.56 0.72 0.70

Mira Pharmaceuticals Quarterly Data
Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.11 0.30 0.08 0.70 0.12
MIRA
13GF Score
Mira Pharmaceuticals Inc MIRA
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Mira Pharmaceuticals Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Mira Pharmaceuticals's Total Liabilities for the fiscal year that ended in Dec. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=0.702+(0+0
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=0.70

Total Liabilities=Total Assets (A: Dec. 2025 )-Total Equity (A: Dec. 2025 )
=11.094-10.392
=0.70

Mira Pharmaceuticals's Total Liabilities for the quarter that ended in Mar. 2026 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=0.115+(0+0
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=0.12

Total Liabilities=Total Assets (Q: Mar. 2026 )-Total Equity (Q: Mar. 2026 )
=9.464-9.349
=0.12

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of $0.12 Mil mean?
Mira Pharmaceuticals (MIRA) has a Total Liabilities of $0.12 Mil as of Mar. 2026. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Mira Pharmaceuticals and its competitors.
Is Mira Pharmaceuticals' Total Liabilities too high?
Mira Pharmaceuticals' current Total Liabilities is $0.12 Mil. Overall, Mira Pharmaceuticals has a GF Score™ of 13/100, reflecting its overall financial health beyond just this single metric.
How does Mira Pharmaceuticals' Total Liabilities compare to NSRX and SCLX?
Mira Pharmaceuticals' Total Liabilities of $0.12 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Drug Manufacturers company?
A good Total Liabilities depends on the Drug Manufacturers industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Mira Pharmaceuticals and its competitors. Mira Pharmaceuticals's current Total Liabilities is $0.12 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mira Pharmaceuticals stock overvalued right now?
Mira Pharmaceuticals (MIRA) has a current Total Liabilities of $0.12 Mil. The current Total Liabilities is $0.12 Mil. Mira Pharmaceuticals' overall GF Score™ is 13/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Mira Pharmaceuticals (MIRA), the current Total Liabilities is $0.12 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Mira Pharmaceuticals Business Description

Address 1200 Brickell Avenue, Suite 1950 No. 1183, Miami, FL, USA, 33133
Mira Pharmaceuticals Inc is a clinical-stage pharmaceutical development company focused on developing novel oral small-molecule therapeutics for neurologic, neuropsychiatric, metabolic, and inflammatory disorders. The company's pipeline includes three product candidates: Ketamir-2, MIRA-55, and SKNY-1, three drug candidates designed to address unmet medical needs across neuropathic and inflammatory pain, central nervous system disorders, and metabolic and behavioral conditions. The company operates as a single operating and reportable segment.
13GF Score

Get the complete analysis for MIRA

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.93
Price